Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.10.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BZ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CK.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.36NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.5.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.41NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.75.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CR.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FS.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.54NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
N.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.15 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.348NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.575NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.4 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.442NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.1 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2.5.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.600NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.12 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.525 (Eta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used